Efficient generation of bispecific IgG antibodies by split intein mediated protein trans-splicing system

por Han, Lei, Chen, Junsheng, Ding, Kai, Zong, Huifang, Xie, Yueqing, Jiang, Hua, Zhang, Baohong, Lu, Huili, Yin, Weihan, Gilly, John, Zhu, Jianwei
Publicado 2017

A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer

por Zhou, Yuexian, Zong, Huifang, Han, Lei, Xie, Yueqing, Jiang, Hua, Gilly, John, Zhang, Baohong, Lu, Huili, Chen, Jie, Sun, Rui, Pan, Zhidi, Zhu, Jianwei
Publicado 2020

Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases

por Blackman, Marcia A., Marchionni, Mark A., Gilly, John, Hepburn, Matthew, Innis, Bruce L., Barrett, Alan D.T., Kester, Kent E., Mascola, John R., Cummings, James F., Monath, Thomas P., Cassetti, M. Cristina, Kim, Jerome H., Saville, Melanie, Thomas, Stephen J.
Publicado 2019

Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD

por Ma, Hang, Guo, Yingying, Tang, Haoneng, Tseng, Chien-Te K., Wang, Lei, Zong, Huifang, Wang, Zhenyu, He, Yang, Chang, Yunsong, Wang, Shusheng, Huang, Haiqiu, Ke, Yong, Yuan, Yunsheng, Wu, Mingyuan, Zhang, Yuanyuan, Drelich, Aleksandra, Kempaiah, Kempaiah Rayavara, Peng, Bi-Hung, Wang, Ailin, Yang, Kaiyong, Yin, Haiyang, Liu, Junjun, Yue, Yali, Xu, Wenbo, Zhu, Shuangli, Ji, Tianjiao, Zhang, Xiaoju, Wang, Ziqi, Li, Gang, Liu, Guangchun, Song, Jingjing, Mu, Lingling, Xiang, ZongShang, Song, Zhangyi, Chen, Hua, Bian, Yanlin, Zhang, Baohong, Chen, Hui, Zhang, Jiawei, Liao, Yunji, Zhang, Li, Yang, Li, Chen, Yi, Gilly, John, Xiao, Xiaodong, Han, Lei, Jiang, Hua, Xie, Yueqing, Zhou, Qiang, Zhu, Jianwei
Publicado 2022